Can Pegasys cause liver damage?

PEGASYS can cause serious side effects including: blood problems, thyroid problems, blood sugar problems, serious eye problems, serious liver problems, worsening of liver problems including liver failure and death, lung problems, inflammation of the pancreas, inflammation of the intestines, serious allergic reactions …

What are the side effects of Sofosbuvir?

Sofosbuvir may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

diarrhea.
headache.
muscle pain.
difficulty falling asleep or staying asleep.
irritability.
itching.
rash.

What does peginterferon alfa 2a do?

Peginterferon alfa-2a injection is used alone or together with other medicines (eg, ribavirin [Copegus®, Rebetol®], boceprevir [Victrelis®], and telaprevir [Incivek®]) to treat chronic hepatitis C infection. It is also used to treat chronic hepatitis B infection.

Is Pegasys chemotherapy?

Drug type: Pegaspargase is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug.

Can Hep C come back after interferon treatment?

It’s possible, but rare, for hepatitis C infection to reappear after apparently successful treatment. Relapses usually occur in the first few months after blood testing to confirm that the virus is no longer detectable.

Does sofosbuvir cure hep C?

Sofosbuvir is effective for treating infection with HCV genotype 1,2,3, or 4, and in clinical trials, 50% to 90% of individuals treated with the drug cleared the hepatitis C virus from their blood.

What is peginterferon used for?

Peginterferon alfa-2a is used alone or in combination with other medications to treat chronic (long-term) hepatitis C infection (swelling of the liver caused by a virus) in people who show signs of liver damage.

Is peginterferon an immunosuppressant?

Yes, Plegridy is an immunosuppressant because it affects how the immune system works. It is thought to work by stopping the immune system from attacking the myelin sheath.

Is Pegasys an immunotherapy?

Peginterferon alfa-2a (Pegasys®) is an Immunotherapy Regimen for Polycythemia Vera.